Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: PRT011
MIFTS: 44

Protein C Deficiency

Categories: Blood diseases, Rare diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Protein C Deficiency

About this section

MalaCards integrated aliases for Protein C Deficiency:

Name: Protein C Deficiency 12 74 52 25 54 43 15 17 71
Autosomal Recessive Thrombophilia Due to Congenital Protein C Deficiency 52
Severe Hereditary Thrombophilia Due to Congenital Protein C Deficiency 52
Congenital Thrombotic Disease, Due to Protein C Deficiency 71
Autosomal Recessive Thrombophilia Due to Pc Deficiency 52
Hereditary Thrombophilia Due to Protein C Deficiency 25
Proc Deficiency 25

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Blood diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:3756
MeSH 43 D020151
NCIt 49 C99025
SNOMED-CT 67 76407009
ICD10 32 D68.59
UMLS 71 C0398625 C2930896
Sources

Summaries for Protein C Deficiency

About this section
Genetics Home Reference : 25 Protein C deficiency is a disorder that increases the risk of developing abnormal blood clots; the condition can be mild or severe. Individuals with mild protein C deficiency are at risk of a type of blood clot known as a deep vein thrombosis (DVT). These clots occur in the deep veins of the arms or legs, away from the surface of the skin. A DVT can travel through the bloodstream and lodge in the lungs, causing a life-threatening blockage of blood flow known as a pulmonary embolism (PE). While most people with mild protein C deficiency never develop abnormal blood clots, certain factors can add to the risk of their development. These factors include increased age, surgery, inactivity, or pregnancy. Having another inherited disorder of blood clotting in addition to protein C deficiency can also influence the risk of abnormal blood clotting. In severe cases of protein C deficiency, infants develop a life-threatening blood clotting disorder called purpura fulminans soon after birth. Purpura fulminans is characterized by the formation of blood clots in the small blood vessels throughout the body. These blood clots block normal blood flow and can lead to localized death of body tissue (necrosis). Widespread blood clotting uses up all available blood clotting proteins. As a result, abnormal bleeding occurs in various parts of the body, which can cause large, purple patches on the skin. Individuals who survive the newborn period may experience recurrent episodes of purpura fulminans.

MalaCards based summary : Protein C Deficiency, also known as autosomal recessive thrombophilia due to congenital protein c deficiency, is related to budd-chiari syndrome and splenic infarction. An important gene associated with Protein C Deficiency is PROC (Protein C, Inactivator Of Coagulation Factors Va And VIIIa), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Collagen chain trimerization. The drugs Protein C and Fibrinolytic Agents have been mentioned in the context of this disorder. Affiliated tissues include skin, lung and liver, and related phenotypes are Decreased replication of vaccinia virus (VACV) and cardiovascular system

NIH Rare Diseases : 52 Protein C deficiency is a disorder that increases a person's risk to develop abnormal blood clots due to a deficiency of the Protein C, a protein in the body that prevents blood clotting. It may be inherited or acquired. Inherited deficiency of protein C can lead to familial thrombophilia (increased tendency toward thrombosis). It is caused by mutations in the PROC gene , and in most cases is transmitted in an autosomal dominant way; a few people inherit an abnormal allele from both parents and may have a more severe disease (please see autosomal recessive protein C deficiency ) because they have very low levels of active protein C. Acquired protein C deficiency may be caused by large blood clots, liver disease, disseminated intravascular coagulation (DIC), infection (sepsis), vitamin K deficiency, use of warfarin or certain types of chemotherapy . While m ost people with protein C deficiency do not have problems, some are at risk for a type of clot called deep vein thrombosis (DVT), which can travel through the bloodstream and become stuck in the lung, causing pulmonary embolism . Also, abnormal bleeding can occur in various parts of the body causing purple patches on the skin. Treatment depend on the symptoms severity. Most people do not need any treatment. However, in situations of clot risk such as pregnancy, surgery or trauma, prevention treatment may be indicated.

Wikipedia : 74 Protein C deficiency is a rare genetic trait that predisposes to thrombotic disease. It was first... more...

Sources

Related Diseases for Protein C Deficiency

About this section

Diseases related to Protein C Deficiency via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 326)
# Related Disease Score Top Affiliating Genes
1 budd-chiari syndrome 31.8 SERPINC1 MTHFR F5 F2 APOH
2 splenic infarction 30.2 SERPINC1 F2 APOH
3 vitamin k deficiency bleeding 30.2 SERPINC1 F9 F2
4 sagittal sinus thrombosis 30.1 SERPINC1 F5 F2
5 purpura 30.0 THBD SERPINC1 PROCR PROC F2 APOH
6 esophageal varix 30.0 SERPINC1 F2
7 cavernous sinus thrombosis 29.9 SERPINC1 F2
8 prothrombin-related thrombophilia 29.8 MTHFR F2
9 raynaud phenomenon 29.8 THBD APOH
10 hemophilia b 29.8 SERPINC1 F9 F2
11 purpura fulminans 29.7 THBD SERPINC1 PROCR PROC F5 F2
12 neonatal stroke 29.7 SERPINE1 PROC MTHFR
13 hepatic infarction 29.7 SERPINC1 F2 APOH
14 marantic endocarditis 29.7 SERPINC1 F2 APOH
15 compartment syndrome 29.7 SERPINC1 F2
16 endocarditis 29.6 SERPINE1 SERPINC1 F2 APOH
17 pulmonary hypertension 29.6 THBD SFTPC SERPINE1 SERPINC1 F2
18 intracranial thrombosis 29.6 SERPINC1 MTHFR F5 F2 APOH
19 antithrombin iii deficiency 29.6 SERPINC1 MTHFR F5 F2 APOH
20 coronary thrombosis 29.6 SERPINE1 SERPINC1 F2
21 lateral sinus thrombosis 29.6 SERPINC1 MTHFR F2
22 pregnancy loss, recurrent 1 29.6 MTHFR F5 APOH
23 infective endocarditis 29.5 SERPINE1 F2 APOH
24 varicose veins 29.5 THBD SERPINC1 MTHFR F5 F2
25 amaurosis fugax 29.5 SERPINE1 MTHFR F5
26 atrial heart septal defect 29.4 SERPINC1 MTHFR F2
27 osteonecrosis 29.3 SERPINE1 SERPINC1 MTHFR F2
28 legg-calve-perthes disease 29.3 THBD SERPINE1 SERPINC1 F5 APOH
29 cerebral sinovenous thrombosis 29.3 MTHFR F5 F2 APOH
30 thrombophlebitis 29.3 SERPINE1 SERPINC1 PROC MTHFR F5 F2
31 central retinal vein occlusion 29.2 SERPINC1 MTHFR F5 F2 APOH
32 disseminated intravascular coagulation 29.2 THBD SERPINE1 SERPINC1 PROCR F9 F5
33 venous insufficiency 29.2 SERPINE1 MTHFR F5 F2
34 portal vein thrombosis 29.1 SERPINE1 SERPINC1 PROC MTHFR F5 F2
35 arteriosclerosis 29.1 THBD SERPINE1 SERPINC1
36 buerger disease 29.1 SERPINE1 MTHFR F2 APOH
37 ischemic colitis 29.0 SERPINE1 SERPINC1 F5 F2 APOH
38 thrombophilia due to thrombin defect 28.9 THBD SERPINE1 SERPINC1 PROCR PROC MTHFR
39 livedoid vasculitis 28.8 SERPINE1 SERPINC1 MTHFR F2 APOH
40 essential thrombocythemia 28.7 THBD SERPINE1 SERPINC1 MTHFR F2
41 peripheral vascular disease 28.7 THBD SERPINE1 SERPINC1 MTHFR F5 F2
42 afibrinogenemia, congenital 28.6 SERPINE1 SERPINC1 F5 F2 CFP
43 pulmonary embolism 28.6 THBD SERPINE1 SERPINC1 PROC MTHFR F9
44 hemorrhagic disease 28.6 THBD SERPINE1 SERPINC1 F9 F5 F2
45 protein s deficiency 28.5 THBD SERPINE1 SERPINC1 PROC MTHFR F5
46 retinal vein occlusion 28.5 SERPINE1 SERPINC1 MTHFR F5 F2 APOH
47 eclampsia 28.4 THBD SERPINE1 SERPINC1 MTHFR F2 APOH
48 thrombophilia due to activated protein c resistance 28.4 THBD SERPINE1 SERPINC1 MTHFR F9 F5
49 homocysteinemia 28.3 THBD SERPINE1 SERPINC1 MTHFR F5 F2
50 vascular disease 28.3 THBD SERPINE1 SERPINC1 MTHFR F5 F2

Graphical network of the top 20 diseases related to Protein C Deficiency:



Diseases related to Protein C Deficiency
Sources

Symptoms & Phenotypes for Protein C Deficiency

About this section

GenomeRNAi Phenotypes related to Protein C Deficiency according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased replication of vaccinia virus (VACV) GR00362-A 8.62 PROC THBD

MGI Mouse Phenotypes related to Protein C Deficiency:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.11 CFP F2 F5 F9 FOXM1 PROC
2 homeostasis/metabolism MP:0005376 10.1 APOH CFP F2 F5 F9 FOXM1
3 immune system MP:0005387 9.96 CFP F2 F9 FOXM1 PROC PROCR
4 mortality/aging MP:0010768 9.77 APOH CFP F2 F5 F9 FOXM1
5 liver/biliary system MP:0005370 9.76 F5 F9 FOXM1 MTHFR PROC SERPINC1
6 respiratory system MP:0005388 9.1 F2 FOXM1 PROC SERPINE1 SFTPC THBD
Sources

Drugs & Therapeutics for Protein C Deficiency

About this section

Drugs for Protein C Deficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 9)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Protein C Approved Phase 3
2 Fibrinolytic Agents Phase 3
3 Drotrecogin alfa activated Phase 2
4 Anti-Infective Agents Phase 2
5
Enoxaparin Approved 9005-49-6 772
6
Testosterone Approved, Experimental, Investigational 58-22-0, 481-30-1 10204 6013
7 Hormone Antagonists
8 Androgens
9 Hormones

Interventional clinical trials:

(show all 11)
# Name Status NCT ID Phase Drugs
1 A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency Completed NCT00157118 Phase 2, Phase 3 Protein C Concentrate (Human) Vapor Heated
2 A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of Drotrecogin Alfa (Activated) Administered as a Continuous 96-hr Infusion to Adult Patients With Septic Shock Completed NCT00604214 Phase 3 Drotrecogin alfa (activated);Placebo
3 Administration of Protein C Concentrates in Adult Critically Ill Septic Patients Terminated NCT01705808 Phase 3 Protein C concentrate
4 Prospective, Randomized Phase II Clinical Trial of Activated Protein C (Xigris) Versus Placebo for the Treatment of Acute Lung Injury Terminated NCT00112164 Phase 2 Xigris
5 A Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND Completed NCT00161720 Protein C Concentrate (Human) Vapor Heated
6 Ceprotin Treatment Registry Completed NCT01127529
7 Sepsis-Associated Purpura Fulminans International Registry - Europe Recruiting NCT02238795
8 Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial Active, not recruiting NCT02600260 Enoxaparin
9 Serum Androgen Levels as a Marker for the Severity of Preeclampsia Active, not recruiting NCT03744988
10 Investigation of Ghrelin Levels in Patients With Protein C Deficiency Not yet recruiting NCT04180657
11 Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy Withdrawn NCT01810237 Dabigatran.

Search NIH Clinical Center for Protein C Deficiency

Cochrane evidence based reviews: protein c deficiency

Sources

Genetic Tests for Protein C Deficiency

About this section
Sources

Anatomical Context for Protein C Deficiency

About this section

MalaCards organs/tissues related to Protein C Deficiency:

40
Skin, Lung, Liver, Testes, Heart, Endothelial, Bone Marrow
Sources

Publications for Protein C Deficiency

About this section

Articles related to Protein C Deficiency:

(show top 50) (show all 1306)
# Title Authors PMID Year
1
Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. 61 54
19200981 2010
2
[Interstitial lung disease in the course of the surfactant protein C deficiency coexisting with the primary humoral immunodeficiency - case study]. 54 61
20461694 2010
3
Thrombophilia investigation in Malaysian women with recurrent pregnancy loss. 54 61
20144172 2009
4
Severe purpura fulminans due to coexistence of homozygous protein C deficiency and homozygous methylenetetrahydrofolate reductase mutation. 61 54
19954370 2009
5
[Cerebral venous thrombosis: when etiology makes the difference]. 54 61
19921552 2009
6
Fulminant sepsis/meningitis due to Haemophilus influenzae in a protein C-deficient heterozygote treated with activated protein C therapy. 61 54
18751723 2009
7
Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations. 61 54
19373522 2009
8
Thrombophilia: 2009 update. 54 61
19289024 2009
9
Activated protein C concentrate treatment for skin necrosis under warfarin treatment in severe genetic protein C deficiency combined with prothrombin mutation and factor V Leiden. 54 61
19190829 2009
10
Deficiency of the natural anticoagulant proteins in women with pregnancy related venous thromboembolism. 54 61
19514602 2009
11
High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. 61 54
19132194 2009
12
Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy. 54 61
19707467 2008
13
Protein C deficiency. 54 61
19141162 2008
14
Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients. 61 54
18160601 2008
15
Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. 54 61
18824642 2008
16
A model for the formation, growth, and lysis of clots in quiescent plasma. A comparison between the effects of antithrombin III deficiency and protein C deficiency. 54 61
18539301 2008
17
Arteriovenous thrombosis in chronic renal failure patients receiving renal replacement therapy. 61 54
18760065 2008
18
Etiological profile of stroke and its relation with prothrombotic states. 54 61
18759085 2008
19
Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. 54 61
18285537 2008
20
Hemostasis activation in thrombophilic subjects with or without a history of venous thrombosis. 61 54
17895509 2008
21
Severe protein C deficiency from compound heterozygous mutations in the PROC gene in two Korean adult patients. 54 61
18573519 2008
22
Risk factors of venous thromboembolism in thai patients. 54 61
18192106 2007
23
Prothrombotic risk factors in children with hemiplegic cerebral palsy. 61 54
17875083 2007
24
Arterial thrombosis and the role of thrombophilia. 54 61
17768691 2007
25
The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty. 61 54
17710975 2007
26
Hirudin treatment for multiple thromboses in a preterm infant with inherited thrombophilia. 54 61
17473583 2007
27
Myocardial infarction and venous thrombosis in a 42-year old woman with heterozygous methylenetetrahydrofolate reductase (MTHRF) gene mutation, hyperhomocysteinemia, and protein C deficiency. 54 61
17360059 2007
28
Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome. 61 54
17442092 2007
29
Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator. 61 54
17116837 2006
30
The relationship between pregnancy induced hypertension and congenital thrombophilia. 61 54
16883445 2006
31
Stroke in childhood: experience in Istanbul, Turkey. 54 61
16636011 2006
32
The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease. 54 61
16607693 2006
33
Cardiopulmonary bypass for a coronary artery bypass graft patient with heterozygous protein C deficiency and protein S deficiency. 54 61
16615690 2006
34
Prothrombotic abnormalities in childhood ischaemic stroke. 54 61
16039697 2006
35
The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty. 54 61
16330983 2005
36
Thrombophilia testing in patients with venous thrombosis. 61 54
16055356 2005
37
Protein C Sapporo (protein C Glu 25 --> Lys): a heterozygous missense mutation in the Gla domain provides new insight into the interaction between protein C and endothelial protein C receptor. 54 61
16363234 2005
38
[Venous thromboembolic disease: which coagulation screening, for whom, when?]. 61 54
16240880 2005
39
The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. 61 54
16135581 2005
40
Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian stroke patients admitted to a rehabilitation hospital. 61 54
16109904 2005
41
Protein S deficiency is common in a healthy Thai population. 61 54
16623037 2005
42
Thrombophilia in children with cystic fibrosis. 54 61
15678507 2005
43
Homozygous type I Protein C deficiency in neonatal purpura fulminans with a novel frame-shift deletion of 10 base pairs in exon 8 of PROC gene. 54 61
15748260 2005
44
Ethnic differences in cerebral venous thrombosis. 61 54
15644626 2005
45
Hydroxychloroquine and surfactant protein C deficiency. 61 54
15647591 2005
46
Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update. 61 54
15678268 2005
47
[Primary thrombophilia. Report of 93 cases and 12 asymptomatic relatives]. 54 61
15743157 2004
48
Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study. 54 61
15309526 2004
49
Frequency of hereditary thrombophilia: an AKUH experience. 61 54
15461212 2004
50
R147W mutation of PROC gene is common in venous thrombotic patients in Taiwanese Chinese. 61 54
15114590 2004
Sources

Variations for Protein C Deficiency

About this section
Sources

Expression for Protein C Deficiency

About this section
Search GEO for disease gene expression data for Protein C Deficiency.
Sources

Pathways for Protein C Deficiency

About this section

Pathways related to Protein C Deficiency according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Response to elevated platelet cytosolic Ca2+ 65
Show member pathways
 12.93 THBD SERPINE1 SERPINC1 PROCR PROC HRG
2
Collagen chain trimerization 65
Show member pathways
 12.52 THBD SERPINC1 PROC F9 F5 F2
3
Cell surface interactions at the vascular wall 65
Show member pathways
 11.92 THBD PROCR PROC F2
4
Formation of Fibrin Clot (Clotting Cascade) 65
Show member pathways
 11.76 THBD SERPINE1 SERPINC1 PROCR PROC F9
5
Gamma carboxylation, hypusine formation and arylsulfatase activation 65
Show member pathways
 11.64 PROC F9 F2
6
Complement and coagulation cascades 36 1
11.39 THBD SERPINE1 SERPINC1 PROCR PROC F9
7
Warfarin Pathway, Pharmacodynamics 60
10.61 PROC F9 F2
8
Dissolution of Fibrin Clot 65
10.52 SERPINE1 HRG
Sources

GO Terms for Protein C Deficiency

About this section

Cellular components related to Protein C Deficiency according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.95 SERPINE1 SERPINC1 PROCR HRG F9 F2
2 extracellular region GO:0005576 9.9 SFTPC SERPINE1 SERPINC1 PROCR PROC HRG
3 endoplasmic reticulum lumen GO:0005788 9.73 SERPINC1 PROC F9 F5 F2 CFP
4 blood microparticle GO:0072562 9.61 SERPINC1 HRG F2
5 Golgi lumen GO:0005796 9.54 PROC F9 F2
6 platelet alpha granule lumen GO:0031093 9.5 SERPINE1 HRG F5
7 collagen-containing extracellular matrix GO:0062023 9.5 SERPINE1 SERPINC1 HRG F9 F2 CFP
8 extracellular space GO:0005615 9.36 THBD SFTPC SERPINE1 SERPINC1 PROCR PROC

Biological processes related to Protein C Deficiency according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 ER to Golgi vesicle-mediated transport GO:0006888 9.8 PROC F9 F5 F2
2 cellular protein metabolic process GO:0044267 9.8 SFTPC SERPINC1 PROC F5 F2
3 platelet degranulation GO:0002576 9.78 SERPINE1 HRG F5 APOH
4 blood coagulation GO:0007596 9.76 THBD SERPINC1 PROCR PROC HRG F9
5 negative regulation of endopeptidase activity GO:0010951 9.73 SERPINE1 SERPINC1 HRG
6 fibrinolysis GO:0042730 9.63 SERPINE1 HRG F2
7 negative regulation of blood coagulation GO:0030195 9.62 THBD SERPINE1 PROC APOH
8 blood coagulation, intrinsic pathway GO:0007597 9.61 F9 F2 APOH
9 regulation of blood coagulation GO:0030193 9.56 SERPINC1 HRG F2 APOH
10 negative regulation of cell adhesion mediated by integrin GO:0033629 9.55 SERPINE1 HRG
11 cytolysis by host of symbiont cells GO:0051838 9.54 HRG F2
12 positive regulation of blood coagulation GO:0030194 9.54 SERPINE1 F2 APOH
13 negative regulation of platelet activation GO:0010544 9.52 THBD F2
14 negative regulation of coagulation GO:0050819 9.51 PROCR PROC
15 negative regulation of fibrinolysis GO:0051918 9.35 THBD SERPINE1 HRG F2 APOH
16 hemostasis GO:0007599 9.23 THBD SERPINC1 PROCR PROC HRG F9

Molecular functions related to Protein C Deficiency according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 10.13 THBD SFTPC SERPINE1 SERPINC1 PROCR PROC
2 serine-type endopeptidase activity GO:0004252 9.43 PROC F9 F2
3 serine-type peptidase activity GO:0008236 9.33 PROC F9 F2
4 serine-type endopeptidase inhibitor activity GO:0004867 9.13 SERPINE1 SERPINC1 HRG
5 heparin binding GO:0008201 8.92 SERPINC1 HRG F2 APOH
Sources

Sources for Protein C Deficiency

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....